Medpace Holdings, Inc. (MEDP): Total Assets
$1.98B
As of 2025-12-31
$2.06B
As of 2026-06-30
+13.5%
3-year compound annual growth
+7.3%
5-year compound annual growth
+7.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.98B | -6.0% | 2026-02-10, Balance as of period end |
| 2024-12-31 | $2.10B | +26.8% | 2026-02-10, Balance as of period end |
| 2023-12-31 | $1.66B | +22.5% | 2025-02-11, Balance as of period end |
| 2022-12-31 | $1.35B | -18.5% | 2024-02-13, Balance as of period end |
| 2021-12-31 | $1.66B | +19.4% | 2023-02-14, Balance as of period end |
| 2020-12-31 | $1.39B | +21.7% | 2022-02-15, Balance as of period end |
| 2019-12-31 | $1.14B | +18.1% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $967.93M | +1.8% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $950.72M | -2.9% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $979.11M | -0.5% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $984.04M | n/a | 2017-02-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $1.98B | -6.0% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $7.14B | -5.2% |
| Incyte Corp (INCY) | 2025-12-31 | $6.96B | +27.8% |
| Icon PLC (ICLR) | 2025-12-31 | $16.27B | -2.2% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $29.94B | +11.3% |
| NRC Health (NRC) | 2025-12-31 | $134.88M | +1.8% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $202.51M | -15.4% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $300.91M | -7.6% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $44.58M | +6.9% |
Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗